Literature DB >> 24826842

Computer-aided discovery of aromatic l-α-amino acids as agonists of the orphan G protein-coupled receptor GPR139.

Vignir Isberg1, Kirsten B Andersen, Christoph Bisig, Gunnar P H Dietz, Hans Bräuner-Osborne, David E Gloriam.   

Abstract

GPR139 is an orphan G protein-coupled receptor expressed mainly in the central nervous system. We developed a pharmacophore model based on known GPR139 surrogate agonists which led us to propose aromatic-containing dipeptides as potential ligands. Upon testing, the dipeptides demonstrated agonism in the Gq pathway. Next, in testing all 20 proteinogenic l-α-amino acids, L-tryptophan and l-phenylalanine were found to have EC50 values of 220 and 320 μM, respectively, making them the first putative endogenous agonists for GPR139.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24826842     DOI: 10.1021/ci500197a

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  20 in total

Review 1.  Identifying ligands at orphan GPCRs: current status using structure-based approaches.

Authors:  Tony Ngo; Irina Kufareva; James Lj Coleman; Robert M Graham; Ruben Abagyan; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

2.  High-throughput screening of antagonists for the orphan G-protein coupled receptor GPR139.

Authors:  Jia Wang; Lin-yun Zhu; Qing Liu; Morten Hentzer; Garrick Paul Smith; Ming-wei Wang
Journal:  Acta Pharmacol Sin       Date:  2015-06-01       Impact factor: 6.150

Review 3.  Hunting for the function of orphan GPCRs - beyond the search for the endogenous ligand.

Authors:  Raise Ahmad; Stefanie Wojciech; Ralf Jockers
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

4.  Identification and SAR of Glycine Benzamides as Potent Agonists for the GPR139 Receptor.

Authors:  Curt A Dvorak; Heather Coate; Diane Nepomuceno; Michelle Wennerholm; Chester Kuei; Brian Lord; David Woody; Pascal Bonaventure; Changlu Liu; Timothy Lovenberg; Nicholas I Carruthers
Journal:  ACS Med Chem Lett       Date:  2015-07-20       Impact factor: 4.345

5.  The orphan receptor GPR139 signals via Gq/11 to oppose opioid effects.

Authors:  Hannah M Stoveken; Stefano Zucca; Ikuo Masuho; Brock Grill; Kirill A Martemyanov
Journal:  J Biol Chem       Date:  2020-06-23       Impact factor: 5.157

6.  Orphan receptor ligand discovery by pickpocketing pharmacological neighbors.

Authors:  Tony Ngo; Andrey V Ilatovskiy; Alastair G Stewart; James L J Coleman; Fiona M McRobb; R Peter Riek; Robert M Graham; Ruben Abagyan; Irina Kufareva; Nicola J Smith
Journal:  Nat Chem Biol       Date:  2016-12-19       Impact factor: 15.040

7.  Novel Agonist Bioisosteres and Common Structure-Activity Relationships for The Orphan G Protein-Coupled Receptor GPR139.

Authors:  Mohamed A Shehata; Anne C Nøhr; Delphine Lissa; Christoph Bisig; Vignir Isberg; Kirsten B Andersen; Kasper Harpsøe; Fredrik Björkling; Hans Bräuner-Osborne; David E Gloriam
Journal:  Sci Rep       Date:  2016-11-10       Impact factor: 4.379

8.  The role of orphan receptor GPR139 in neuropsychiatric behavior.

Authors:  Maria Dao; Hannah M Stoveken; Yan Cao; Kirill A Martemyanov
Journal:  Neuropsychopharmacology       Date:  2021-01-21       Impact factor: 8.294

9.  Protection of Primary Dopaminergic Midbrain Neurons by GPR139 Agonists Supports Different Mechanisms of MPP(+) and Rotenone Toxicity.

Authors:  Kirsten Bayer Andersen; Jens Leander Johansen; Morten Hentzer; Garrick Paul Smith; Gunnar P H Dietz
Journal:  Front Cell Neurosci       Date:  2016-06-28       Impact factor: 5.505

10.  The orphan G protein-coupled receptor GPR139 is activated by the peptides: Adrenocorticotropic hormone (ACTH), α-, and β-melanocyte stimulating hormone (α-MSH, and β-MSH), and the conserved core motif HFRW.

Authors:  Anne Cathrine Nøhr; Mohamed A Shehata; Alexander S Hauser; Vignir Isberg; Jacek Mokrosinski; Kirsten B Andersen; I Sadaf Farooqi; Daniel Sejer Pedersen; David E Gloriam; Hans Bräuner-Osborne
Journal:  Neurochem Int       Date:  2016-12-01       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.